An official turf cutting ceremony marking the beginning of the building of a new £2.4m aerial walkway which will link Weston Park Cancer Centre to the Royal Hallamshire Hospital took place today (Friday 15th February ).
Kirsten Major, Interim Chief Executive for Sheffield Teaching Hospitals NHS Foundation Trust, was joined by staff from across both hospital sites to cut the first turf at the ceremony.
The new glass walkway, which has been sympathetically fabricated to blend in with the existing skyline, will enable patients to be directly transferred across to the Hallamshire Hospital and vice versa without the need to be transported by an ambulance or taxi. This will mean staff will not have to wait for transport to be available before they can transfer patients between the two hospitals.
A mum-of-three who says that the hardest thing about having cancer was that her youngest daughter wouldn't kiss her for fear of catching the disease has become one of the first in the world to take part in a groundbreaking first-in-human cancer study at Weston Park Hospital.
Amanda Horsman, 43, of Warmsworth, Doncaster was told she had an advanced head and neck cancer just days before Christmas 2016, but decided to keep the news of her diagnosis hidden from her three young children, Franchesca 10, Kristian 9, and Holly 6, until the new year.
Now she has become one of only 20 people in the world and one of only three in Sheffield to have taken part in a cutting-edge clinical trial looking to see if a new drug known as MTL-005 can affect
Patients have praised staff at Sheffield Teaching Hospitals NHS Foundation Trust for the care they provide.
In the latest national cancer patient experience survey, the Trust scored highly in a number of key areas in the survey.
In particular quality of care was rated higher than the national average.
Ensuring patients and their families had information about support groups, were treated with dignity and respect, and involved in decisions about their care and treatment were also rated highly by patients.
Professor Derek Rosario, consultant urological surgeon at Sheffield Teaching Hospitals, has been named the chief investigator of a brand new £2.5m National Institute for Health Research study investigating whether a new exercise programme could improve the lives of men suffering with prostate cancer.
The unique STAMINA (Supported exercise training for men with prostate cancer on androgen deprivation therapy) trial is one of the largest studies of its kind anywhere in the world and will look to investigate whether a longer-term supported exercise programme – embedded in NHS cancer care and delivered via expert commercial partners in the community – can counter the problems caused by androgen deprivation therapy (ADT).